Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Pletcher

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Pediatrics|April 3, 2013
Re: Childhood lipid screening: evidence and conflictsThomas B Newman, Mark J Pletcher, Stephen B Hulley
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
The Need for Change in Generating Evidence for the Critically IllMatthieu Legrand, Mark J Pletcher, Scott Y H Kim
JAMA Internal Medicine|December 28, 2021
Effectiveness of an Analytics-Based Intervention for Reducing Sleep Interruption in Hospitalized Patients: A Randomized Clinical TrialNader Najafi, Andrew Robinson, Mark J Pletcher, et al.
Pediatrics|July 25, 2012
Overly aggressive new guidelines for lipid screening in children: evidence of a broken processThomas B Newman, Mark J Pletcher, Stephen B Hulley
JAMA Internal Medicine|August 18, 2016
Lipid Screening in Children: Low-Value CareThomas B Newman, Alan R Schroeder, Mark J Pletcher
The New England Journal of Medicine|February 7, 2019
Wearable Cardioverter-Defibrillator after Myocardial InfarctionByron K Lee, Mark J Pletcher, Jeffrey E Olgin
Patient Related Outcome Measures|February 23, 2018
PCORnet's Collaborative Research GroupsMark J Pletcher, Christopher B Forrest, Thomas W Carton
JAMA Internal Medicine|January 4, 2018
Whom to Treat for High Blood Pressure-Time for a Precision ApproachAndrew E Moran, Mark J Pletcher, Kirsten Bibbins-Domingo
Annals of Internal Medicine|March 8, 2006
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysisMichael Pignone, Stephanie Earnshaw, Jeffrey A Tice, et al.
Mayo Clinic Proceedings|June 3, 2023
In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive PatientsAlanna M Chamberlain, Rhonda M Cooper-DeHoff, Mark J Pletcher
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Pediatrics|April 3, 2013
Re: Childhood lipid screening: evidence and conflictsThomas B Newman, Mark J Pletcher, Stephen B Hulley
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
The Need for Change in Generating Evidence for the Critically IllMatthieu Legrand, Mark J Pletcher, Scott Y H Kim
JAMA Internal Medicine|December 28, 2021
Effectiveness of an Analytics-Based Intervention for Reducing Sleep Interruption in Hospitalized Patients: A Randomized Clinical TrialNader Najafi, Andrew Robinson, Mark J Pletcher, et al.
Pediatrics|July 25, 2012
Overly aggressive new guidelines for lipid screening in children: evidence of a broken processThomas B Newman, Mark J Pletcher, Stephen B Hulley
JAMA Internal Medicine|August 18, 2016
Lipid Screening in Children: Low-Value CareThomas B Newman, Alan R Schroeder, Mark J Pletcher
The New England Journal of Medicine|February 7, 2019
Wearable Cardioverter-Defibrillator after Myocardial InfarctionByron K Lee, Mark J Pletcher, Jeffrey E Olgin
Patient Related Outcome Measures|February 23, 2018
PCORnet's Collaborative Research GroupsMark J Pletcher, Christopher B Forrest, Thomas W Carton
JAMA Internal Medicine|January 4, 2018
Whom to Treat for High Blood Pressure-Time for a Precision ApproachAndrew E Moran, Mark J Pletcher, Kirsten Bibbins-Domingo
Annals of Internal Medicine|March 8, 2006
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysisMichael Pignone, Stephanie Earnshaw, Jeffrey A Tice, et al.
Mayo Clinic Proceedings|June 3, 2023
In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive PatientsAlanna M Chamberlain, Rhonda M Cooper-DeHoff, Mark J Pletcher
Pageof 27